BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32395510)

  • 1. High RPS11 level in hepatocellular carcinoma associates with poor prognosis after curative resection.
    Zhou C; Sun J; Zheng Z; Weng J; Atyah M; Zhou Q; Chen W; Zhang Y; Huang J; Yin Y; Mao H; Zhang Z; Yi Y; Ren N
    Ann Transl Med; 2020 Apr; 8(7):466. PubMed ID: 32395510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection.
    Fu YP; Yi Y; Huang JL; Jing CY; Sun J; Ni XC; Lu ZF; Cao Y; Zhou J; Fan J; Qiu SJ
    Oncologist; 2017 May; 22(5):561-569. PubMed ID: 28438885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of nomogram models of inflammatory markers based on clinical database to predict prognosis for hepatocellular carcinoma after surgical resection.
    Mao S; Yu X; Sun J; Yang Y; Shan Y; Sun J; Mugaanyi J; Fan R; Wu S; Lu C
    BMC Cancer; 2022 Mar; 22(1):249. PubMed ID: 35255845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nomograms Incorporating the CNLC Staging System Predict the Outcome of Hepatocellular Carcinoma After Curative Resection.
    Liao R; Wei XF; Che P; Yin KL; Liu L
    Front Oncol; 2021; 11():755920. PubMed ID: 35127471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic nomogram for patients with hepatocellular carcinoma underwent adjuvant transarterial chemoembolization following curative resection.
    Jing CY; Fu YP; Zheng SS; Yi Y; Shen HJ; Huang JL; Xu X; Lin JJ; Zhou J; Fan J; Ren ZG; Qiu SJ; Zhang BH
    Medicine (Baltimore); 2017 Mar; 96(11):e6140. PubMed ID: 28296727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low expression of WW domain-containing oxidoreductase associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection.
    Zhou C; Chen W; Sun J; Atyah M; Yin Y; Zhang W; Guo L; Ye Q; Dong Q; Shi Y; Ren N
    Cancer Med; 2018 Jul; 7(7):3031-3043. PubMed ID: 29905011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of prognostic nomograms for single large and huge hepatocellular carcinoma after curative resection.
    Wang JC; Hou JY; Chen JC; Xiang CL; Mao XH; Yang B; Li Q; Liu QB; Chen J; Ye ZW; Peng W; Sun XQ; Chen MS; Zhou QF; Zhang YJ
    Eur J Cancer; 2021 Sep; 155():85-96. PubMed ID: 34371445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Nomogram Model to Predict the Recurrence-Free Survival and Overall Survival of Hepatocellular Carcinoma.
    Zhang SW; Zhang NN; Zhu WW; Liu T; Lv JY; Jiang WT; Zhang YM; Song TQ; Zhang L; Xie Y; Zhou YH; Lu W
    Front Oncol; 2022; 12():946531. PubMed ID: 35936698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A New Prognostic Algorithm Predicting HCC Recurrence in Patients With Barcelona Clinic Liver Cancer Stage B Who Received PA-TACE.
    Hu S; Gan W; Qiao L; Ye C; Wu D; Liao B; Yang X; Jiang X
    Front Oncol; 2021; 11():742630. PubMed ID: 34745962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
    Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
    Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinogen and C-reactive protein score is a prognostic index for patients with hepatocellular carcinoma undergoing curative resection: a prognostic nomogram study.
    Gan W; Yi Y; Fu Y; Huang J; Lu Z; Jing C; Fan J; Zhou J; Qiu S
    J Cancer; 2018; 9(1):148-156. PubMed ID: 29290780
    [No Abstract]   [Full Text] [Related]  

  • 12. Overexpression of interleukin-35 associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection.
    Fu YP; Yi Y; Cai XY; Sun J; Ni XC; He HW; Wang JX; Lu ZF; Huang JL; Cao Y; Zhou J; Fan J; Qiu SJ
    Br J Cancer; 2016 Mar; 114(7):767-76. PubMed ID: 27002937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison and validation of the prognostic value of preoperative systemic immune cells in hepatocellular carcinoma after curative hepatectomy.
    Liao R; Peng C; Li M; Li DW; Jiang N; Li PZ; Ding X; Wu Q; Du CY; Gong JP
    Cancer Med; 2018 Apr; 7(4):1170-1182. PubMed ID: 29533004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
    Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
    BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of a Nomogram by Integrating Molecular Markers and Tumor-Node-Metastasis Staging System for Predicting the Prognosis of Hepatocellular Carcinoma.
    Huang XT; Chen LH; Huang CS; Li JH; Cai JP; Chen W; Yin XY
    Dig Surg; 2019; 36(5):426-432. PubMed ID: 30481744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nomograms for Predicting Hepatocellular Carcinoma Recurrence and Overall Postoperative Patient Survival.
    Ma L; Deng K; Zhang C; Li H; Luo Y; Yang Y; Li C; Li X; Geng Z; Xie C
    Front Oncol; 2022; 12():843589. PubMed ID: 35296018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection.
    Gan W; Huang JL; Zhang MX; Fu YP; Yi Y; Jing CY; Fan J; Zhou J; Qiu SJ
    J Surg Oncol; 2018 Jun; 117(7):1540-1547. PubMed ID: 29572833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Validation of a Model Including Distinct Vascular Patterns to Estimate Survival in Hepatocellular Carcinoma.
    Lin WP; Xing KL; Fu JC; Ling YH; Li SH; Yu WS; Zhang YF; Zhong C; Wang JH; Chen ZY; Lu LH; Wei W; Guo RP
    JAMA Netw Open; 2021 Sep; 4(9):e2125055. PubMed ID: 34515782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a prognostic model based on the albumin-to-fibrinogen ratio (AFR) and gamma-glutamyl transpeptidase-to-platelet ratio (GPR) in hepatocellular carcinoma patients.
    Zhang J; Wang T; Xu L; Wang P; Zhang M; Xu M
    Clin Chim Acta; 2020 Dec; 511():107-116. PubMed ID: 33035501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel inflammation-based prognostic nomograms for individualized prediction in hepatocellular carcinoma after radical resection.
    Zeng J; Zeng J; Wu Q; Lin K; Zeng J; Guo P; Zhou W; Liu J
    Ann Transl Med; 2020 Sep; 8(17):1061. PubMed ID: 33145280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.